About FDA
How can I get access to a drug that is in testing but has not yet been approved?
Drugs that are being tested but are not yet approved are called investigational (or experimental) drugs and patients can get access in two ways:
- They can participate in the drug testing process, known as a clinical trial, or
- They can be given the drug as part of a special program, more formally known as expanded access.
In general, to obtain access to a drug that is in testing but has not yet been approved, a patient must meet the entrance criteria and volunteer to participate in a clinical study of the drug. More information about ongoing clinical trials is available at ClinicalTrials.gov.
Sometimes, people with serious or immediately life-threatening illnesses cannot wait until a drug that could possibly help them stay alive is approved. In some of these cases, FDA authorizes the manufacturer to provide patients with access to a drug that is still being tested for safety and effectiveness but is not yet approved.
FDA does not create expanded access programs; these programs are created by the drug’s manufacturer, sometimes at the request of a doctor whose patient is in urgent need of the medication. If there is no established expanded access program in effect for which the patient qualifies, FDA can consider a request for expanded access on a case-by-case basis.
Show all related FDA Basics Questions
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- How FDA Evaluates Regulated Products: Drugs
- FDA Webinar on Prescription Drug Shortages
- FDA Webinar on "Bad Ads" Program
- FDA Basics Webinar on Generic Drugs
- FDA Basics Videos: Tim Coté on Orphan Drugs
- What is an FDA Drug Safety Communication?
- What is counterfeit medicine?
- FDA Basic Video: Interview with John Jenkins on New Drugs (Video)
- What are unapproved drugs and why are they on the market?
- How can I stay better informed about drugs? Is there a reliable website FDA recommends?
- How do I discard medicine that I no longer need, do I just throw it in the garbage?
- How do I report a bad reaction to medicine or medication error to FDA?
- Does FDA approve the proprietary names of prescription drugs?
- What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
- How does FDA help consumers when drug shortages happen?
- Does FDA approve the information given out by pharmacies when I pick up my medicine?
- How does FDA decide when a drug is not safe enough to stay on the market?
- How do I find out if a drug is approved? Is there a Web site I can go to?
- What is the approval process for a new prescription drug?
- What is a Warning Letter?
- Can FDA ban direct-to-consumer drug advertising?
How helpful was this information?
